Eyeworld Daily News – 2024 EyeWorld Daily News Friday
EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news
EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news
What could CEQUA provide for patients inadequately controlled on Restasis®?
Scott Geller outlines the pitfalls of not properly listening to eye patients
SEATTLE — In this Healio Video Perspective from the ARVO meeting, George O. Waring IV, MD, FACS, discusses the Tecnis Odyssey’s tolerance to refractive error.
Researchers at Massachusetts Eye and Ear led a phase 1/2 trial, which included 14 participants, that found the experimental treatment was safe and efficacious.
In this study, we identify risk factors that predict the progression of acquired vitelliform lesions (AVLs) over time.
“We show, for the first time in this study, that many fibroblast cells are actually produced by these excessive endothelial cells. We must find a…
Philippe Sourdille, MD, describes the design, mechanism, and surgical procedure for a glaucoma device that is placed in a location in the eye that potentially…
Sophia Pathai talks about the Hevolution Foundation’s commitment to healthspan and the role of Nafetha within it
Join the National Eye Institute’s Office of Data Science and Health Informatics (ODSHI) for their upcoming event, Building AI Datasets for the Future of AI…
To compare biomechanical and vascular metrics between the eyes of patients with asymmetric glaucoma (ASYMM) and those with symmetric glaucoma (SYMM). Patients and Methods: Forty-five…